Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

NCT01147991 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Head and Neck Cancer
Lymphoma
Lymphoproliferative Disorder
Nonneoplastic Condition

Interventions

BIOLOGICAL: EBNA1 C-terminal/LMP2 chimeric protein-expressing recombinant modified vaccinia Ankara vaccine
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Cancer Research UK